Moderna faces weak post-pandemic vaccine demand and financial struggles, with limited near-term catalysts. Click here to read ...

Scientists have developed a needle-free vaccine method using dental floss to trigger strong immune responses at key mucosal ...

French pharmaceutical giant Sanofi reported a sharp increase in second-quarter profit on Thursday, driven by higher net sales ...

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...

President Donald Trump's administration on Tuesday announced it would terminate 22 federal contracts for mRNA-based vaccines, ...

The US Department of Health and Human Services is ending contracts to develop vaccines using messenger RNA technology, ...

Two other Covid vaccines expected to be available this fall, Novavax’s Nuvaxovid and Moderna’s mNexspike, are also restricted ...